Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas.
Saved in:
| Title: | Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas. |
|---|---|
| Authors: | Gurkan D; Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey., Ceren Akin A; Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey., Sahin H; Department of Gynecologic Oncology, Malatya Education and Research Hospital, Malatya, Turkey., Aytac Tohma Y; Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey., Sahin EA; Department of Obstetrics and Gynecology, Malatya Education and Research Hospital, Malatya, Turkey., Gunakan E; Department of Obstetrics and Gynecology, Keçiören Education and Research Hospital, Ankara, Turkey., Iflazoglu N; Department of Surgical Oncology, Malatya Education and Research Hospital, Malatya, Turkey., Nihan Haberal A; Department of Pathology, School of Medicine, Baskent University, Ankara, Turkey., Ayhan A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey. |
| Source: | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology [J Obstet Gynaecol] 2020 May; Vol. 40 (4), pp. 551-557. Date of Electronic Publication: 2019 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8309140 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1364-6893 (Electronic) Linking ISSN: 01443615 NLM ISO Abbreviation: J Obstet Gynaecol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
